Sandoz is a global leader in off-patent medicines, specializing in the development of generics and biosimilars.

Our portfolio includes more than 1,500 high-quality products covering major therapeutic areas, helping to improve access to effective and affordable treatments. In 2006, we pioneered the introduction of biosimilars as a new category in healthcare.

Today, we market 10 successful biosimilars globally and have 24 more in development. With a presence in over 100 countries, we positively impact the lives of millions of patients and support the sustainability of healthcare systems.

At Sandoz, we are committed to expanding access to medical innovation, driving solutions that transform the future of healthcare.